Recruiting Pulmonary Embolism Studies in Charleston
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
PRECIDENTD is a randomized, open label, pragmatic clinical trial designed to compare rates of the total number of cardiovascular, kidney, and death events among two alternative treatments for patients...
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
This is a 52-week, randomized, placebo-controlled, double-blind, parallel group, multicenter study of depemokimab in adults with uncontrolled HES receiving standard of care (SoC) therapy. The study w...
About Pulmonary Embolism Clinical Trials in Charleston
Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.
There are currently 2 pulmonary embolism clinical trials recruiting participants in Charleston, SC. These studies are seeking a combined 6,123 participants. Research is being sponsored by Brigham and Women's Hospital, GlaxoSmithKline. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Embolism Clinical Trials in Charleston — FAQ
Are there pulmonary embolism clinical trials in Charleston?
Yes, there are 2 pulmonary embolism clinical trials currently recruiting in Charleston, SC. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Charleston?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Charleston research site will contact you about next steps.
Are clinical trials in Charleston free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Charleston studies also compensate for your time and travel.
What pulmonary embolism treatments are being tested?
The 2 active trials in Charleston are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.
Data updated March 2, 2026 from ClinicalTrials.gov